WHY THIS PRODUCT IS LISTED
Other / see reason
The products contain DMAA, also known as 1,3-dimethylamylamine, methylhexamine or geranium extract, which is not permitted in dietary supplements.
Product description & recall reason
The recall record describes “PHEnFX (TM), PHENO 550 mg, PHARMACEUTICAL GRADE, 90 CAPSULES, Manufactured for: Beta Labs, LTD, Newark, DE 19711, UPC…”; the source reports: “The products contain DMAA, also known as 1,3-dimethylamylamine, methylhexamine or geranium extract, which is not permitted in dietary supplements.”
Based on the official recall record; packaging and sales claims have not been verified. Verify with the official source ↗
Identify the product
- Product description
- PHEnFX (TM), PHENO 550 mg, PHARMACEUTICAL GRADE, 90 CAPSULES, Manufactured for: Beta Labs, LTD, Newark, DE 19711, UPC 029882559802
- Brand
- Not supplied by this source
- Lot, batch, UPC & other codes
- Lot # 1205129, Exp 12/16
- Quantity
- 743 units
Where it came from & where it went
- Recalling firm
- Beta Labs
- Recalling firm address
- 2 W GE Patterson Ave Apt 103; N/A; Memphis; TN; 38103-6429; United States
- Product production / origin location
- Not supplied by this source
- Distribution — source wording
- nationwide and UK
States identified in the source
Nationwide — includes all U.S. states.
State matching is derived from the source’s distribution wording, which may be incomplete. The recalling company’s address is not used as the distribution location.
A recalling firm’s address is not necessarily where the food was grown or manufactured. Distribution can change; check the official notice.